Dr. Sarah Brooke Fleisig, MD

Dr. Fleisig practices at Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County.

Dr. Fleisig's NPI, 1275827941, was assigned on May 31, 2011. Dr. Fleisig graduated from The Warren Alpert Medical School of Brown University in 2011. Dr. Fleisig's California license number on file is A152713.

Dr. Fleisig's primary practice is Alameda Health System - Highland Hospital, at 1411 East 31st Street, Oakland, CA 94602 in Alameda County. The practice phone is (510) 437-4800.

Dr. Fleisig's primary practice is Alameda Health System - Highland Hospital in Oakland, California, part of Alameda County. Dr. Fleisig is also affiliated with Alta Bates Summit Medical Center | Alta Bates Campus. The medical group on file is Alameda Health System. Dmand AI also links Dr. Fleisig to 1 more hospital, 1 community health center, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Fleisig's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleisig practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Fleisig's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Fleisig is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Fleisig's licenses on file in 3 states: California, Nevada and Connecticut.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer and prostate cancer among the conditions Dr. Fleisig treats.

CMS data shows 115 Medicare services from Dr. Fleisig across 4 procedure codes in 2024, for 54 Medicare patients. Medicare paid $11,541 for them.

CMS counts 54 Medicare patients who saw Dr. Fleisig in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 59% have cancer. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleisig's median patient age at 66, with 51% women.

In 2024, Dr. Fleisig wrote 415 Medicare Part D claims for 53 patients. 72% of them were for generic drugs. CMS names the drug for 211 of them, across 9 drugs with 11 or more claims each, at $600,816 in total drug cost. In 2023, CMS named 157 claims across 8 drugs.

Dr. Fleisig accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Fleisig in 2017. 2017 was the busiest year, with 3. Dr. Fleisig's most frequent co-authors are Diego Andres Adrianzen Herrera, MD, Mathew Birnbaum, MD and Mark I. Jacobson, MD.

CMS Open Payments shows 9 general payments to Dr. Fleisig from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 50% of the total. Pfizer Inc. paid the most, $76.

Dmand AI lists 1 award for Dr. Fleisig, most recently Gold Humanism Honors Society in 2007.

Dr. Fleisig graduated from The Warren Alpert Medical School of Brown University in 2011. Dr. Fleisig is a member of ASCO and ASH.

Dr. Fleisig is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.